| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 6 | |
| #2 | Finland | 3 | |
| #3 | EPO (European Patent Office) | 1 | |
| #4 | Hungary | 1 | |
| #5 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Agriculture | |
| #4 | Measurement | |
| #5 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Peptides | |
| #3 | Animal care | |
| #4 | Medical preparations | |
| #5 | Microorganisms | |
| #6 | Heterocyclic compounds | |
| #7 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Saarma Mart | 11 |
| #2 | Andressoo Jaan-Olle | 4 |
| #3 | Timmusk Tonis | 3 |
| #4 | Tuominen Raimo | 3 |
| #5 | Lindholm Päivi | 2 |
| #6 | Lauren Juha | 2 |
| #7 | Bespalov Maxim | 2 |
| #8 | Lindahl Maria | 1 |
| #9 | Airavaara Mikko | 1 |
| #10 | Leppänen Veli-Matti | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2014259192A1 | Transgenic animal comprising a deletion or functional deletion of the 3'utr of an endogenous gene | |
| FI20070808A0 | Split variants of GDNF and uses thereof | |
| US2008057516A1 | Receptor for GDNF family ligands | |
| FI20002874A0 | Compounds that are associated with or derived from a novel BH3-only binding pro-apoptotic backbone that has neuron-specific expression and anti-apoptotic activity in neurons, and their use | |
| FI991197A0 | Neurotropic factors in the treatment of pelvic peripheral dysfunction |